The rate of infusion reactions to total-dose intravenous iron polymaltose is very low, but the frequency and severity of adverse reactions following the infusion are unknown. In 50 consecutive patients, adverse reactions developed up to 2 days after the infusion in 26% and lasted 1-8 days (median 4). Severe systemic reactions occurred in 8%. Patients should be warned of the chance of delayed reactions and an alternative iron preparation should be considered if parenteral iron is again indicated.
Details
- Topic
- Policies and guidelines
- Date published
- 02 Jul 2013
- Size
- 4 pages
- Author
- Department of Health & Human Services
- Update frequency
- Annual
- Available format
Reviewed 03 July 2013